Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbCellera Biologics Inc. - Common Shares (NQ:ABCL)

7.970 +0.370 (+4.87%)
Streaming Delayed Price Updated: 2:46 PM EDT, Jul 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AbCellera Biologics Inc. - Common Shares

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom ↗
AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider. 
Via InvestorPlace
News headline image
AbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients
From AbCellera Biologics Inc.
Via Business Wire
News headline image
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
7 Growth Stocks That Could Double Your Money in 2023 ↗
For investors that really want to roll the dice, these are the enticing growth stocks that could double your money. 
Via InvestorPlace
News headline image
AbCellera Biologics (ABCL) Q1 2023 Earnings Call Transcript ↗
ABCL earnings call for the period ending March 31, 2023. 
Via The Motley Fool
News headline image
Recap: AbCellera Biologics Q1 Earnings ↗
 
Via Benzinga
News headline image
4 Analysts Have This to Say About AbCellera Biologics ↗
 
Via Benzinga
News headline image
Preview: AbCellera Biologics's Earnings ↗
 
Via Benzinga
News headline image
AbCellera Reports Q1 2023 Business Results
From AbCellera Biologics Inc.
Via Business Wire
News headline image
How AI Is Revolutionizing Tech, and Why You Should Invest in These Leading Companies ↗
Check out these compelling opportunities. 
Via The Motley Fool
News headline image
7 Stocks Under $10 That Analysts Love ↗
While these ideas might seem super cheap in a bad way, these stocks under $10 also rank among Wall Street analysts’ top picks. 
Via InvestorPlace
News headline image
AbCellera Presents New Data on T-Cell Engager Platform at AACR 2023
From AbCellera Biologics Inc.
Via Business Wire
News headline image
1 Sector Received $6.1 Billion in AI Investments Last Year: 3 Top Stocks to Buy ↗
These companies are leading the way in using AI in healthcare. 
Via The Motley Fool
News headline image
7 Best Stocks Under $10 to Buy in April ↗
Although these stocks under $10 to buy may be cheap, their underlying businesses could yield significant upside. 
Via InvestorPlace
News headline image
AbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023
From AbCellera Biologics Inc.
Via Business Wire
News headline image
7 Thrilling Biotech Stocks for Aggressive Investors to Buy ↗
Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own. 
Via InvestorPlace
News headline image
7 Stocks to Bet On if You Want to Be Richer Than Elon Musk ↗
If you can handle the heat of extreme speculation, you may want to throw some gambling funds at these stocks that can make you rich. 
Via InvestorPlace
News headline image
AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023
From AbCellera Biologics Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023 ↗
 
Via Benzinga
News headline image
AbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AbCellera Biologics (ABCL) Q4 2022 Earnings Call Transcript ↗
ABCL earnings call for the period ending December 31, 2022. 
Via The Motley Fool
News headline image
AbCellera Reports Full Year 2022 Business Results
From AbCellera Biologics Inc.
Via Business Wire
News headline image
The 7 Most Undervalued Biotech Stocks to Buy in February 2023 ↗
Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy. 
Via InvestorPlace
News headline image
AbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AbCellera to Report Full Year 2022 Financial Results on February 21, 2023
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AbCellera Announces that the U.S. Patent Trial and Appeal Board Upholds Microfluidic Cell Culture Patent
From AbCellera Biologics Inc.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.